Karen Moxon, professor of biomedical engineering, in her lab at UC Davis. Photo by Reeta Asmai/UC Davis.
By Aditi Risbud Bartl
In the last decade, researchers in academia and the technology sector have been racing to unlock the potential of artificial intelligence. In parallel with federally-funded efforts from the National Institutes of Health and the National Science Foundation, heavy-hitters such as Microsoft, Facebook and Google are deeply invested in artificial intelligence.
As part of the BRAIN Initiative, many UC Davis investigators are studying the nervous system and developing new technologies to investigate brain function.
Full post: Karen Moxon: Decoding the Brain
(1140 words, 1 image, estimated 4:34 mins reading time)
Spinal injuries are life-changing, and it used to be thought that recovery of limb movement below the injury was impossible. But new research is showing that with the right therapies, the body can find ways to work around spinal injuries. Professor Karen Moxon of the UC Davis Department of Biomedical Engineering talks about her work with rats and how they can recover from injury.
Listen: Three Minute Egghead: New Insight on Spinal Injuries (Soundcloud)
Working Around Spinal Injuries (News release)
Permanent link to this post
(97 words, estimated 23 secs reading time)
Neutrophils are the most abundant type of white blood cell. They play a vital role in defending us from infections, by engulfing and destroying bacteria and viruses or cancerous cells. A new study by UC Davis engineering student Emmet Francis, working with Professor Volkmar Heinrich in the Department of Biomedical Engineering, adds to our knowledge of how neutrophils are drawn towards infection sites and how they can attack their targets.
First, Francis and Heinrich looked at how isolated neutrophils respond to chemical messengers called anaphylatoxins. These molecules guide immune cells to their targets but can cause severe illness in excessive amounts.
By Holly Ober
A new technique developed at UC Davis may have broken the barrier to rapid assembly of pure protein synthesis machinery outside of living cells.
E. coli bacteria tagged with different colors produced different mixtures of proteins. Together, the bacterial consortium makes all the proteins needed for mRNA translation/protein synthesis (Fernando Villarreal, UC Davis)
In order to reconstitute cellular reactions outside of biological systems, scientists need to produce the proteins involved. Rapid yet high purity reconstitution of the cellular reactions is critical for the high-throughput study of cellular pathways and cell-free diagnostic tests for various diseases. Reconstituting cellular reactions outside cells, however, requires the separate expression and purification of each protein required to execute the reactions. This process is expensive and time consuming, making the production of more than several proteins at once extremely challenging.
By Holly Ober
Two UC Davis graduates have started a company incubated in the TEAM manufacturing facility at the UC Davis Department of Biomedical Engineering.
Arshia Firouzi and Gurkern Sufi met in 2011 as Freshmen living in Tercero Dormitories at UC Davis and quickly became friends. Arshia majored in Electrical Engineering and Gurkern in Biotechnology, and they worked with the mentorship of Professor Marc Facciotti to explore their shared interest in the intersection of electronics and biology. In 2015 they won a VentureWell grant for a research project, which they pursued in TEAM’s Molecular Prototyping and Bioinnovation Laboratory. By the end of their project, they had come up with an idea that grew into a company that could usher in a new era for laboratories all over the world.